December 16, 2013 8:30am EST
Download as PDF
MIAMI--(BUSINESS WIRE)--
OPKO Health, Inc. (NYSE: OPK )
today announced the details of its upcoming investor conference call.
The Company will host a conference call and webcast on Tuesday, December
17, 2013, for investors and analysts. At 8:30 A.M. (ET) on December 17,
investors and analysts can access the call by dialing 800-859-8150 and
entering 94380747 as the conference ID number. The call will also be
available via live webcast at www.investorcalendar.com .
Webcast participants should allot extra time to register before the
webcast begins.
A replay of the call will be available shortly after the call ends on
December 17, 2013 through January 17, 2014. To access the replay, dial
877-919-4059 and enter 73872602 as the conference ID number.
ABOUT OPKO HEALTH, INC.
OPKO is a multinational biopharmaceutical and diagnostics company that
seeks to establish industry leading positions in large, rapidly growing
markets by leveraging its discovery, development and commercialization
expertise and novel and proprietary technologies. For more information,
visit http://www.opko.com .
SAFE HARBOR STATEMENT
This press release contains "forward-looking statements," as that
term is defined under the Private Securities Litigation Reform
Act of 1995 (PSLRA), which statements may be identified by words such as
"expects," "plans," "projects," "will," "may," "anticipates,"
"believes," "should," "intends," "estimates," and other words of similar
meaning, including statements regarding the potential for our
therapeutic and diagnostic product candidates, as well as other
non-historical statements about our expectations, beliefs or intentions
regarding our business, technologies and products, financial condition,
strategies or prospects. Many factors could cause our actual activities
or results to differ materially from the activities and results
anticipated in forward-looking statements. These factors include those
described in our filings with the Securities and Exchange Commission, as
well as the risks inherent in funding, developing and obtaining
regulatory approvals of new, commercially-viable and competitive
products and treatments. In addition, forward-looking statements may
also be adversely affected by general market factors, competitive
product development, product availability, federal and state regulations
and legislation, the regulatory process for new products and
indications, manufacturing issues that may arise, patent positions and
litigation, among other factors. The forward-looking statements
contained in this press release speak only as of the date the statements
were made, and we do not undertake any obligation to update
forward-looking statements. We intend that all forward-looking
statements be subject to the safe-harbor provisions of the PSLRA.
OPKO Heath, Inc.
Steve D. Rubin, +1 305-575-4100
Executive
Vice President - Administration
or
Juan F. Rodrigez, +1
Chief Financial Officer
Source: OPKO Heath, Inc.
Released December 16, 2013
email Email Alerts
location_city Company Profile
contact_page Contacts
rss_feed RSS News Feed
account_tree Sitemap
Apply on OPKO Health (Ireland)’s careers page